Fred Alger Management’s AnaptysBio ANAB Stock Holding History

Fred Alger Management’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-17,958	Closed	-$602K	–	412
2024 Q3	$602K	Buy	+17,958	New	+$613K	﹤0.01%	370
2024 Q2	–	Sell	-33,882	Closed	-$763K	–	429
2024 Q1	$763K	Buy	+33,882	New	+$802K	﹤0.01%	379
2023 Q1	–	Sell	-6,177	Closed	-$191K	–	520
2022 Q4	$191K	Buy	+6,177	New	+$174K	﹤0.01%	430
2020 Q1	–	Sell	-8,000	Closed	-$130K	–	549
2019 Q4	$130K	Buy	+8,000	New	+$189K	﹤0.01%	414
2018 Q2	–	Sell	-4,500	Closed	-$468K	–	543
2018 Q1	$468K	Hold	4,500	–	–	﹤0.01%	376
2017 Q4	$453K	Buy	+4,500	New	+$331K	﹤0.01%	379

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Fred Alger Management's ANAB Position: Q4 2024 in Review

Fred Alger Management sold out of AnaptysBio (ANAB) in Q4 2024, closing a stake of 17,958 shares — an estimated $602K sold.

Fred Alger Management first reported a position in ANAB in Q4 2017 and held it in 6 quarters. The position peaked at $763K in Q1 2024. 135 funds tracked by Wall St. Rank hold ANAB as of Q4 2024.

Fred Alger Management reported no remaining AnaptysBio position as of Q4 2024 after selling out during the quarter.
Fred Alger Management sold 17,958 AnaptysBio shares in Q4 2024, an estimated $602K.
Fred Alger Management first reported a position in AnaptysBio in Q4 2017 and held it in 6 quarters.
Fred Alger Management's AnaptysBio position peaked at $763K in Q1 2024.
135 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2024.

Based on Fred Alger Management's 13F filing for Q4 2024, filed 14 Feb 2025.